BioInvent International Overview

  • Founded
  • 1983
Founded
  • Status
  • Public
  • Employees
  • 78
Employees
  • Stock Symbol
  • BINV
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $4.60
  • (As of Friday Closing)

BioInvent International General Information

Description

BioInvent International AB is a biopharmaceutical company. It develops a pipeline of innovative immuno-oncology therapies for cancer therapy based on its unique F.I.R.S.T technology platform and n-CoDeR antibody library. The products under its pipeline are BI-1206, BT-001, BI-1808, and BI-1910. Its geographical segments are Sweden, Europe, United States, Japan, and Other countries.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Ideon Science Park
  • 223 70 Lund
  • Sweden
+46 046-286 00 00

BioInvent International Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioInvent International Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.60 $4.62 $4.22 - $7.53 $270M 58.5M 55.1K -$0.28

BioInvent International Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 213,031 150,001 48,532 62,189
Revenue 14,737 15,983 9,911 4,430
EBITDA (15,079) (6,943) (13,385) (13,584)
Net Income (16,478) (8,279) (14,657) (14,155)
Total Assets 186,209 97,846 24,184 13,395
Total Debt 3,672 1,415 1,661 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BioInvent International Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioInvent International‘s full profile, request access.

Request a free trial

BioInvent International Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
BioInvent International AB is a biopharmaceutical company. It develops a pipeline of innovative immuno-oncology therapie
Drug Discovery
Lund, Sweden
78 As of 2021
00000
000000000 00000

0000000

tation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehender
0000 000000000
Cambridge, MA
0000 As of 0000
00.00
00000000000 00.00

00000

ute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exc
0000 000000000
Mumbai, India
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioInvent International Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Moderna Therapeutics Formerly VC-backed Cambridge, MA 0000 00.00 00000000000 00.00
00000 Corporation Mumbai, India 00000 00000000
000000 Formerly VC-backed Loos, France 000 00000 000000000. 0 00000
000000 0000000 Corporation Lund, Sweden 0 000.00 000000000 000.00
00000000000 000000 Corporation Raleigh, NC 000 00000 000000 - 000
You’re viewing 5 of 21 competitors. Get the full list »

BioInvent International Executive Team (7)

Name Title Board Seat Contact Info
Stefan Ericsson Chief Financial Officer
Bjorn Frendeus Ph.D Chief Scientific Officer
Cecilia Hofvander Senior Director, Investor Relations
Andres McAllister Ph.D Chief Medical Officer
Martin Welschof Ph.D Chief Executive Officer
You’re viewing 5 of 7 executive team members. Get the full list »

BioInvent International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioInvent International Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioInvent International‘s full profile, request access.

Request a free trial

BioInvent International Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000000 (00- 01-Jan-2017 000000000 00000 00 Buildings and Property
ThromboGenics (TB-403 rights) 05-Jun-2012 Corporate Asset Purchase Buildings and Property
To view BioInvent International’s complete investments history, request access »